Correlation Between Passage Bio and Crinetics Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Passage Bio and Crinetics Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Passage Bio and Crinetics Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Passage Bio and Crinetics Pharmaceuticals, you can compare the effects of market volatilities on Passage Bio and Crinetics Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Passage Bio with a short position of Crinetics Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Passage Bio and Crinetics Pharmaceuticals.
Diversification Opportunities for Passage Bio and Crinetics Pharmaceuticals
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Passage and Crinetics is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Passage Bio and Crinetics Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crinetics Pharmaceuticals and Passage Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Passage Bio are associated (or correlated) with Crinetics Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crinetics Pharmaceuticals has no effect on the direction of Passage Bio i.e., Passage Bio and Crinetics Pharmaceuticals go up and down completely randomly.
Pair Corralation between Passage Bio and Crinetics Pharmaceuticals
Given the investment horizon of 90 days Passage Bio is expected to under-perform the Crinetics Pharmaceuticals. In addition to that, Passage Bio is 2.93 times more volatile than Crinetics Pharmaceuticals. It trades about -0.01 of its total potential returns per unit of risk. Crinetics Pharmaceuticals is currently generating about -0.03 per unit of volatility. If you would invest 5,840 in Crinetics Pharmaceuticals on August 24, 2024 and sell it today you would lose (137.00) from holding Crinetics Pharmaceuticals or give up 2.35% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Passage Bio vs. Crinetics Pharmaceuticals
Performance |
Timeline |
Passage Bio |
Crinetics Pharmaceuticals |
Passage Bio and Crinetics Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Passage Bio and Crinetics Pharmaceuticals
The main advantage of trading using opposite Passage Bio and Crinetics Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Passage Bio position performs unexpectedly, Crinetics Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crinetics Pharmaceuticals will offset losses from the drop in Crinetics Pharmaceuticals' long position.Passage Bio vs. Black Diamond Therapeutics | Passage Bio vs. Revolution Medicines | Passage Bio vs. Stoke Therapeutics | Passage Bio vs. Cabaletta Bio |
Crinetics Pharmaceuticals vs. Viridian Therapeutics | Crinetics Pharmaceuticals vs. Cytokinetics | Crinetics Pharmaceuticals vs. Structure Therapeutics American | Crinetics Pharmaceuticals vs. Passage Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |